C-Encode Logo

FRAX, narrative with BMD table · Westview Imaging Centre, MRN SMP-100250, DOB 1954-01-01

Bone Mineral Density

BONE MINERAL DENSITY DATA:
Compared with: 2024-03-04
DENSITY
(g/cm²)
T-SCORE
Z-SCORE
DENSITY
PRIOR
(g/cm²)
CHANGE
(g/cm²)
CHANGE
(%)
Spine L1-L4.0.936-2.0-0.40.946-0.010-1.1
Left Femoral Neck.0.670-2.6-1.0
Left Total Hip.0.717-2.3-0.90.764-0.047-6.2
Height(cm): 161.2
Weight(kg): 48.4

DIAGNOSTIC CATEGORY: Osteoporosis.

10-YEAR MAJOR OSTEOPOROTIC FRACTURE RISK (FRAX): 11.5%

10-YEAR HIP FRACTURE RISK (FRAX): 2.1%

RISK FACTORS: None.

BONE-ACTIVE DRUG THERAPY: No.

LIMITATIONS: Fracture risk is likely underestimated because an osteoporotic T-score at the lumbar spine, femoral neck, or total hip is not accounted for in FRAX.

INTERVAL CHANGE:
Lumbar Spine: No significant interval change. Left Total Proximal Femur: Significant interval decrease.

RECOMMENDATIONS: Pharmacotherapy is suggested as per the 2023 Osteoporosis Canada guideline. Consider a thoracic and/or lumbar spine x-ray to assess for possible compression fractures. Finding of undiagnosed vertebral fracture(s) can guide appropriate choice and duration of therapy.

FOLLOW-UP: 1 year, given significant interval bone loss.

LSC (least significant change) at Westview Imaging Centre: Lumbar Spine - 0.025 gm/cm² Total Hip - 0.03 gm/cm²

For definitions, follow-up timelines, scanner specifics, and other reference information, visit the Westview Imaging Centre physician resources page. This report follows the CAR Practice Guideline on Bone Mineral Densitometry Reporting: 2024 Update and the Osteoporosis Canada 2023 Clinical Practice Guideline for Management of Osteoporosis and Fracture Prevention in Canada.

Sample output for illustration. Patient details are fictional; the report layout and wording are produced by DXA Encode.